|
[1]
|
世界中医药联合会. 中医基本名词术语中英对照国际标准[S]. 北京: 人民卫生出版社, 2007: 114-118.
|
|
[2]
|
WHO. WHO西太平洋地区传统医学名词术语国际标准[S]. 北京: 北京大学医学出版, 2009: 82-85.
|
|
[3]
|
王晓凯, 童意, 刘月, 周畅, 贾德贤. 以“固精”类术语为例浅析中医英译中隐性逻辑的显性表达[J]. 环球中医药, 2021, 14(12): 2260-2263.
|
|
[4]
|
李经纬, 余瀛鳌, 蔡景峰, 等. 中医大辞典[M]. 北京: 人民卫生出版社, 2018: 1042-1043.
|
|
[5]
|
周恩, 苏琳. 中医药术语英译研究趋势、问题与展望[J]. 中国中西医结合杂志, 2022, 42(6): 754-759.
|
|
[6]
|
Zou, X.S., Shi, L., Yin, H.L., Li, H.P., Wang, M.H., Song, W.C., Luo, L.C., Wu, H.Z., Yang, Y.F., Zan, J.F., Liu, Y.W., Dan, H.X., Yin, Q. and You, P.T. (2022) Compound Gaoziban Tablet Alleviates Depression Toll-Like Receptor 4/Myeloid Differentiation Factor 88/Nuclear Factor-Kappa B Pathway. Journal of Traditional Chinese Medicine, 42, 956-964.
|
|
[7]
|
Zhang, Q., Yue, S.J., Wang, W.X., Chen, Y.Y., Zhao, C.B., Song, Y.J., Yan, D., Zhang, L. and Tang, Y.P. (2021) Potential Role of Gut Microbiota in Traditional Chinese Medicine against COVID-19. The American Journal of Chinese Medicine, 49, 785-803. [Google Scholar] [CrossRef]
|
|
[8]
|
Chai, J.X., Ren, J., Ya, K.X., Xu, F., Ma, Y., Zhu, X.H., Yan, F., Yang, Y.S., Gu, C.Y., Wu, J.F. and Xu, J.H. (2019) Therapeutic Effectiveness of Lishi Oral Liquid Combined with Levocetirizine in Treating Atopic Dermatitis: A Randomized Double-Blind Placebo-Controlled Clinical Trial. Traditional Medicine and Modern Medicine, 2, 179-183. [Google Scholar] [CrossRef]
|
|
[9]
|
Chan, K.W., Wong, V.T. and Tang, S.C.W. (2020) COVID-19: An Update on the Epidemiological, Clinical, Preventive and Therapeutic Evidence and Guidelines of Integrative Chinese-Western Medicine for the Management of 2019 Novel Coronavirus Disease. The American Journal of Chinese Medicine, 48, 737-762. [Google Scholar] [CrossRef]
|